Cardiolinc™, an international research network focusing on next-generation technologies to personalize diagnostics and treatment for cardiovascular disease was formally launched as a non-profit organization (NPO). Founded by Dr. Yvan Devaux and team member Dr. Clarissa Pedrosa da Costa Gomes from the Luxembourg Institute of Health (LIH), and collaborators from the Universities of Bristol, Leicester and Maastricht, Cardiolinc™ helps connect scientists worldwide from multiple disciplines to fight the world’s main cause of death.
Cardiovascular disease is responsible for one in every three deaths globally, generating substantial costs and social burden due to reduced quality of life and premature deaths. To fight this epidemic, Cardiolinc™’s mission is to understand the role of regulatory RNAs in cardiovascular disease and promote research collaborations to drive the development of precision medicine, aiding to faster translate discoveries in the laboratory into the clinical setting.
Cardiolinc™ was born from the Cardiovascular Research Unit in LIH’s Department of Population Health in 2014 on the belief of Dr. Yvan Devaux, its founder, that non-coding RNA research in cardiovascular disease could move faster by collaboration. Since its creation, the network has been serving as a platform to connect scientists worldwide from multiple disciplines. Through Cardiolinc™, these researchers and clinicians are able to find one another, exchange knowledge, share ideas, and build projects towards a common goal.
With the development of novel technologies, it is easier to unravel new knowledge, but it gets increasingly difficult for scientists to conduct groundbreaking research individually. This scenario creates both the opportunity and the need for collaboration. Cardiolinc™ aims to coordinate and facilitate this process. It identifies openings for funding and supports its members to overcome the challenges of multidisciplinary collaboration, creating effective partnerships to bring new therapies to patients sooner, potentially improving the lives of millions of people and reducing healthcare costs.
Despite the ferocious competition in science, collaboration and synergy across disciplines and across academic and industrial organizations can empower groups of researchers. Cardiolinc™ saw the number of its members double last year alone. At the time of the NPO registration, the network was represented by 66 members and 13 industry partners from backgrounds such as cardiology, genetics, molecular biology, computational science, biobanking, and biospecimen science.
Cardiolinc™ as an NPO will be able to provide consulting, transfer knowledge and technology via courses or partnering with industry, write recommendations, develop and improve tools for research, and carry out clinical trials.
To overcome the obstacles of achieving breakthrough science and leap science forward to defeat cardiovascular disease, collaborations and synergies between scientists are key. Revolutionary ideas come from thinking creatively across disciplines and being brave to try new solutions to old problems.
About the Cardiolinc™ network:
Cardiolinc™ is an international research network based in Luxembourg aiming to develop precision medicine by understanding the role of regulatory RNAs in cardiovascular disease and promoting collaborative research. Cardiolinc™ connects over 80 scientists, clinicians, and industry members worldwide from multiple disciplines, such as cardiology, genetics, molecular biology and computational sciences. It coordinates and eases the challenges of multidisciplinary collaboration, creating effective partnerships to translate discoveries into clinical applications. Through Cardiolinc™, Luxembourg is now on the map of international cardiovascular research.
Dr. Clarissa P. da Costa Gomes, Cardiolinc™ coordinator
Luxembourg Institute of Health
1A-B rue Thomas Edison
1445 Strassen, Luxembourg
Dr Malou Fraiture | idw - Informationsdienst Wissenschaft
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences